Rhonda Voskuhl is a Neurology physician affiliated with University of California, Los Angeles. OpenAlex indexes 152 publications with 12,158 citations (h-index 58); ClinicalTrials.gov lists 3 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
300 Medical Plaza
#b200
Los Angeles, CA 900950001
Telephone
310-794-1195Provider last certified this registry record 14 Jan 2020.
Clinical trials
- Estriol Treatment in Multiple Sclerosis (MS): Effect on Cognition
Sponsor: University of California, Los Angeles
- A Combination Trial of Copaxone Plus Estriol in Relapsing Remitting Multiple Sclerosis (RRMS)
Sponsor: University of California, Los Angeles
- Testosterone Treatment for Multiple Sclerosis
Sponsor: University of California, Los Angeles
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Exeltis, USA Inc.Program year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
NIH funding
11 NIH research awards on record, funded 1997–2026 per NIH RePORTER. The latest:
- Neurodegeneration Underlying Distinct Disabilities in Multiple Sclerosis Using a Cell-Specific, Region-Specific, and Sex-Specific Approach
University of California Los Angeles
FY2026$922,109R35NS132150 - Neurodegeneration Underlying Distinct Disabilities in Multiple Sclerosis Using a Cell-Specific, Region-Specific, and Sex-Specific Approach
University of California Los Angeles
FY2025$922,109R35NS132150 - Neurodegeneration Underlying Distinct Disabilities in Multiple Sclerosis Using a Cell-Specific, Region-Specific, and Sex-Specific Approach
University of California Los Angeles
FY2024$894,212R35NS132150
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Sex effects across the lifespan in women with multiple sclerosis
Therapeutic Advances in Neurological Disorders
2020 - The X-linked histone demethylase Kdm6a in CD4+ T lymphocytes modulates autoimmunity
Journal of Clinical Investigation
2019 - Gene expression in oligodendrocytes during remyelination reveals cholesterol homeostasis as a therapeutic target in multiple sclerosis
Proceedings of the National Academy of Sciences
2019
Similar KOLs
Other experts from the same institution or the same specialty.
Gregg Fonarow, MD
University of California, Los Angeles
Dennis Slamon, MD
University of California, Los Angeles
Tomas Ganz, MD
University of California, Los Angeles
Richard Casaburi, MD
University of California, Los Angeles
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”